OnKure Therapeutics, Inc. (OKUR)
OKUR Stock Price Chart
Explore OnKure Therapeutics, Inc. interactive price chart. Choose custom timeframes to analyze OKUR price movements and trends.
OKUR Company Profile
Discover essential business fundamentals and corporate details for OnKure Therapeutics, Inc. (OKUR) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Biotechnology
IPO Date
8 Apr 2021
Employees
46.00
Website
https://onkuretherapeutics.comCEO
Nicholas A. Saccomano
Description
OnKure, Inc., established in 2011 and based in Boulder, Colorado, operates as a biopharmaceutical company primarily engaged in the creation and advancement of precise therapeutic agents for cancer. A core area of their research centers on developing highly selective inhibitors for histone deacetylases. Their current pipeline features OKI-179, an inhibitor specifically engineered to combat a wide spectrum of malignancies, including both blood-related cancers and solid tumor formations.
OKUR Financial Timeline
Browse a chronological timeline of OnKure Therapeutics, Inc. corporate events including earnings releases, dividend announcements, and stock splits.
Upcoming earnings on 11 Aug 2026
EPS estimate is -$0.58, while revenue estimate is $166.67k.
Earnings released on 5 May 2026
EPS came in at -$1.11 falling short of the estimated -$0.81 by -37.04%.
Earnings released on 12 Mar 2026
EPS came in at -$0.99 surpassing the estimated -$1.15 by +13.91%.
Earnings released on 6 Nov 2025
EPS came in at -$1.09 surpassing the estimated -$1.20 by +9.17%.
Earnings released on 12 Aug 2025
EPS came in at -$1.14 surpassing the estimated -$1.23 by +7.32%.
Earnings released on 6 May 2025
EPS came in at -$1.19 surpassing the estimated -$1.32 by +9.85%.
Earnings released on 10 Mar 2025
EPS came in at -$1.37 falling short of the estimated -$0.86 by -59.30%.
Earnings released on 7 Nov 2024
EPS came in at -$1.10 falling short of the estimated -$0.97 by -13.40%.
Stock split effective on 7 Oct 2024
Shares were split 1 : 10 , changing the number of shares outstanding and the price per share accordingly.
Earnings released on 13 Aug 2024
EPS came in at -$1.60 falling short of the estimated -$1.00 by -60.00%.
Earnings released on 7 May 2024
EPS came in at -$0.25 surpassing the estimated -$0.37 by +32.43%.
Earnings released on 31 Dec 2023
EPS came in at -$7.00 falling short of the estimated -$5.78 by -21.11%.
Earnings released on 30 Sept 2023
EPS came in at -$1.44 surpassing the estimated -$5.71 by +74.82%.
Earnings released on 30 Jun 2023
EPS came in at -$0.61 surpassing the estimated -$5.30 by +88.43%.
Earnings released on 31 Mar 2023
EPS came in at -$0.65 surpassing the estimated -$6.04 by +89.23%.
Earnings released on 27 Mar 2023
EPS came in at -$5.60 surpassing the estimated -$5.88 by +4.83%.
Earnings released on 8 Nov 2022
EPS came in at -$5.30 surpassing the estimated -$5.72 by +7.29%.
OKUR Stock Performance
Access detailed OKUR performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.
